Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H32O2 |
Molecular Weight | 328.4883 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C
InChI
InChIKey=QGNJRVVDBSJHIZ-QHLGVNSISA-N
InChI=1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9+,18-14+
Molecular Formula | C22H32O2 |
Molecular Weight | 328.4883 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/8801161
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/8801161
Retonol, also known as Vitamin A1, is a vitamin found in food and used as a dietary supplement. It is used to treat and prevent vitamin A deficiency. It is also used to prevent further issues in those who have measles. Retinol is used as a metabolic precursor of retinoic acid to treat skin-related conditions, such as cellulite, skin aging, photodamage.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2354 Sources: https://www.ncbi.nlm.nih.gov/pubmed/30972178 |
|||
Target ID: O95237 Gene ID: 9227.0 Gene Symbol: LRAT Target Organism: Homo sapiens (Human) |
|||
Target ID: Q96NR8 Gene ID: 145226.0 Gene Symbol: RDH12 Target Organism: Homo sapiens (Human) Sources: https://www.drugbank.ca/drugs/DB00162 |
|||
Target ID: Q92781 Gene ID: 5959.0 Gene Symbol: RDH5 Target Organism: Homo sapiens (Human) Sources: https://www.drugbank.ca/drugs/DB00162 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Primary | AQUASOL A Approved UseUsed to treat and prevent symptoms of vitamin A deficiency such as xerophthalmia and night blindness. Used as a dietary supplement to prevent vitamin A deficiency in patients with GI diseases (e.g., malabsorption syndromes) and those with abnormal storage and transport of vitamin A (e.g., abetalipoproteinemia, protein deficiency, diabetes mellitus, hyperthyroidism, fever, liver disease, cystic fibrosis with hepatic involvement). Launch Date1949 |
|||
Palliative | AQUASOL A Approved UseChildren with severe measles have been found to have low serum concentrations of vitamin A; WHO and AAP recommend that vitamin A supplements be given to all children with acute measles, regardless of their country of residence. Launch Date1949 |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Review of acute hydrocephalus caused by administration of vitamin A in massive doses in nursing infants; based on 100 cases]. | 1957 Feb |
|
Vitamin A induced benign intracranial hypertension. | 1976 Feb |
|
Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. | 2000 Oct |
|
[Hypercalcemia due to chronic vitamin A use by an elderly patient with renal insufficiency]. | 2001 Jan 13 |
|
Influence of vitamin A status on the regulation of uridine (5'-)diphosphate-glucuronosyltransferase (UGT) 1A1 and UGT1A6 expression by L-triiodothyronine. | 2001 Mar |
|
The anemia of vitamin A deficiency: epidemiology and pathogenesis. | 2002 Apr |
|
Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. | 2003 Apr |
|
PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation. | 2003 Feb |
|
Vitamin A deficiency leads to increased cell proliferation in olfactory epithelium of mature rats. | 2003 Mar |
|
Vitamin A prevents high fat diet-induced ACF development and modifies the pattern of expression of peroxisome proliferator and retinoic acid receptor m-RNA. | 2004 |
|
Carotenoids and their metabolites are naturally occurring activators of gene expression via the pregnane X receptor. | 2004 Dec |
|
Ocular side effects from herbal medicines and nutritional supplements. | 2004 Oct |
|
Protein and m-RNA expression of farnesyl-transferases, RhoA and RhoB in rat liver hepatocytes: action of perillyl alcohol and vitamin A in vivo. | 2005 |
|
What is the safe dose of vitamin A in children with measles? | 2005 Apr |
|
Retinoid receptor mRNA expression profiles in human bladder cancer specimens. | 2005 Apr |
|
Fortification of maize meal improved the nutritional status of 1-3-year-old African children. | 2005 Aug |
|
beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. | 2005 Aug 15 |
|
Phospho-STAT5 accumulation in nuclear fractions from vitamin A-deficient rat liver. | 2005 Jul 4 |
|
Effect of vitamin A content in cafeteria diet on the expression of nuclear receptors in rat subcutaneous adipose tissue. | 2005 Jun |
|
Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. | 2005 Jun 14 |
|
Extra-hepatic vitamin A concentrations in captive Rhesus (Macaca mulatta) and Marmoset (Callithrix jacchus) monkeys fed excess vitamin A. | 2005 Mar |
|
Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. | 2005 Mar |
|
Development of a versatile reporter assay for studies of retinol uptake and metabolism in vivo. | 2005 Nov 1 |
|
Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells. | 2005 Oct |
|
Comparison of indices of vitamin A status in children with chronic liver disease. | 2005 Oct |
|
Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. | 2005 Sep 20 |
|
Transmembrane protein GDE2 induces motor neuron differentiation in vivo. | 2005 Sep 30 |
|
Effects of nitrofen and vitamins A, C and E on maturation of cultured human H441 pneumocytes. | 2006 |
|
Retinol palmitate protects against myocardial ischemia/reperfusion injury via reducing oxidative stress and inhibiting apoptosis. | 2019 |
Patents
Sample Use Guides
The role of vitamin A (2.72 μM/7 ml culture), a naturally occurring antioxidant upon arsenic-induced genotoxicity; with respect to chromosomal aberrations (structural and numerical) and micronuclei. Whole blood cultures set for 72 h were exposed to test chemicals for a period of 24 h ahead of harvesting. Arsenic concentrations tested in the present study are 0.36, 0.72 and 1.4 μM/7 ml culture. Mitomycin C (MMC), the direct acting mutagen was used as positive control.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:06:55 GMT 2023
by
admin
on
Fri Dec 15 15:06:55 GMT 2023
|
Record UNII |
3LE3D9D6OY
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
3238 (Number of products:173)
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
||
|
DSLD |
2650 (Number of products:125)
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
||
|
NCI_THESAURUS |
C804
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
638034
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
127-47-9
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
100000090581
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
122760
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
CHEMBL986
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
DBSALT001720
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
1716002
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
VITAMIN A ACETATE
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | Description: A yellow to brownish yellow, oily liquid. Solubility: Practically insoluble in water; soluble or partly soluble in dehydrated ethanol R; miscible with organic solvents. Category: Vitamin.Storage: The oily form of Retinol concentrate should be kept in a well-closed and well-filled container, protected from light. Once the container has been opened its contents should be used as soon as possible; any part of the contents not used at once shouldbe protected by an atmosphere of inert gas. Labelling: The designation on the container should state the name of the retinol ester or esters, and their quantities expressed as the content of vitamin A in International Units (IU) per gram, whether any stabilizing agents are added and their quantities, as well as the method of restoring the solution if partial crystallization has occurred. Additional information: Even in the absence of light the oily form of Retinol concentrate is gradually degraded on exposure to ahumid atmosphere, the decomposition being faster at higher temperatures.Partial crystallization may occur in concentrated solutions and upon refrigeration. | ||
|
3LE3D9D6OY
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
m11481
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | Merck Index | ||
|
C1216
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
32095
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
35400
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | RxNorm | ||
|
2372
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
RETINYL ACETATE
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
122045
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
204-844-2
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
C009166
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
DTXSID6021240
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
3LE3D9D6OY
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY | |||
|
SUB04224MIG
Created by
admin on Fri Dec 15 15:06:55 GMT 2023 , Edited by admin on Fri Dec 15 15:06:55 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |